home / stock / canf / canf short
Short Information | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,265 |
Total Actual Volume | 573,048 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 113 |
Average Short Percentage | 0.41% |
Is there a CANF Short Squeeze or Breakout about to happen?
See the CANF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-16-2024 | $2.09 | $2.2374 | $2.24 | $2.04 | 26,727 | 1 | 0% |
05-09-2024 | $2.15 | $2.1418 | $2.2 | $2 | 150,476 | 90 | 0.06% |
05-06-2024 | $2.32 | $2.11 | $2.32 | $2.11 | 20,955 | 260 | 1.24% |
05-02-2024 | $2.09 | $2.03 | $2.21 | $2.01 | 10,925 | 18 | 0.16% |
05-01-2024 | $2.12 | $2.09 | $2.12 | $2.0001 | 27,382 | 9 | 0.03% |
04-30-2024 | $2 | $2.07 | $2.25 | $2 | 45,491 | 500 | 1.1% |
04-29-2024 | $1.98 | $1.97 | $2.02 | $1.95 | 8,739 | 133 | 1.52% |
04-26-2024 | $2 | $1.98 | $2.01 | $1.91 | 8,665 | 5 | 0.06% |
04-23-2024 | $1.9601 | $1.97 | $1.9759 | $1.96 | 3,761 | 4 | 0.11% |
04-17-2024 | $2.095 | $1.96 | $2.11 | $1.94 | 32,005 | 1 | 0% |
04-16-2024 | $2.07 | $2.08 | $2.2909 | $2.03 | 13,213 | 1 | 0.01% |
04-15-2024 | $2.2 | $2.07 | $2.21 | $2.02 | 20,092 | 397 | 1.98% |
04-12-2024 | $2.3155 | $2.1 | $2.34 | $2.1 | 14,349 | 9 | 0.06% |
04-11-2024 | $2.3148 | $2.28 | $2.34 | $2.2 | 11,677 | 5 | 0.04% |
04-10-2024 | $2.21 | $2.35 | $2.4241 | $2.21 | 11,769 | 1 | 0.01% |
04-08-2024 | $2.44 | $2.4 | $2.5 | $2.29 | 9,801 | 3 | 0.03% |
04-05-2024 | $2.35 | $2.35 | $2.57 | $2.2501 | 38,989 | 500 | 1.28% |
04-01-2024 | $2.29 | $2.31 | $2.71 | $2.22 | 75,078 | 301 | 0.4% |
03-08-2024 | $2.17 | $2.21 | $2.25 | $2.16 | 30,513 | 10 | 0.03% |
03-05-2024 | $2.13 | $2.1 | $2.1386 | $2.03 | 12,441 | 17 | 0.14% |
News, Short Squeeze, Breakout and More Instantly...
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
Can-Fite has received agreement from both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) on the current pivotal Phase 3 clinical study Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietar...
ORLANDO, FL / ACCESSWIRE / May 10, 2024 / RedChip Companies will air interviews with Can-Fite BioPharma Ltd. (NYSE American:CANF) and Nutriband Inc. (NASDAQ:NTRB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, May 11, at 7 p.m. Eastern ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announces that the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IN...